It was a mixed day for Daewoong Pharmaceutical Co. Ltd., which disclosed separately on March 28 both the termination of a ...

Researchers from the University of Queensland recently provided details on the discovery and preclinical characterization of ...

Digital therapeutics coupled with drugs has the potential to transform health care and change the way patients are treated, ...

Australia’s top universities are looking more to Asia for research collaborations following threats from the Trump ...

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies activating the immune system to kill tumor cells, representing ...

The first disease modifying therapies for Alzheimer’s may have limited utility in some senses, but they will be a force for ...

In a deal that could reach nearly $2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. has licensed a small molecule for ...

In a recently published study, researchers from the International Centre for Genetic Engineering and Biotechnology in Italy ...

Scientists at Zhengzhou University and affiliated organizations synthesized and optimized a series of thienopyridine indole derivatives leading to the identification of compound [I] as the lead ...

Researchers from Chinese Academy of Sciences detailed the creation of a new dextran sulfate sodium (DSS)-based mouse model of ...

BioWorld recorded 148 updates from phase I to phase III trials, marking a decline from the 171 updates tracked in January.

A variant burden analysis for bipolar disorder was performed using gene-based aggregation of loss-of-function variants in whole-genome sequencing data from Iceland and the UK Biobank; the association ...